The effects of clinical motor variables and medication dosage on working memory in Parkinson's disease

Brain and Cognition

Volumn 82, Issue 2, 2013, Pages 137-145

  Moustafa, Ahmed A ^a,b,c   Bell, Peter ^b   Eissa, Abeer M ^d   Hewedi, Doaa H ^d  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b UniversityofWestern Sydney   (Australia)

^c WESTERN SYDNEY UNIVERSITY   (Australia)

^d AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Akinesia; Disease duration; Dopamine medication dosage; Levodopa equivalent daily dose; Parkinson's disease; Tremor; Working memory delay

Indexed keywords

LEVODOPA;

ADULT; AKINESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DOSE CALCULATION; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; MALE; MEMORY DISORDER; MENTAL TASK; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE; WORKING MEMORY;

AGED; ANTIPARKINSON AGENTS; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 84877339833     PISSN: 02782626     EISSN: 10902147     Source Type: Journal    
DOI: 10.1016/j.bandc.2013.04.001     Document Type: Article

References (95)

1. Agid Y., Ruberg M., Javoy-Agid F., Hirsch E., Raisman-Vozari R., Vyas S., et al. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?. Advances in Neurology 1993, 60:148-164.
2. Amos A. A computational model of information processing in the frontal cortex and basal ganglia. Journal of Cognitive Neuroscience 2000, 12(3):505-519.
3. Ashby F.G., Ell S.W., Valentin V.V., Casale M.B. FROST: A distributed neurocomputational model of working memory maintenance. Journal of Cognitive Neuroscience 2005, 17(11):1728-1743.
4. Barch D.M., Braver T.S., Nystrom L.E., Forman S.D., Noll D.C., Cohen J.D. Dissociating working memory from task difficulty in human prefrontal cortex. Neuropsychologia 1997, 35(10):1373-1380.
5. Battig K., Rosvold H.E., Mishkin M. Comparison of the effects of frontal and caudate lesions on delayed response and alternation in monkeys. Journal of Comparative and Physiological Psychology 1960, 53:400-404.
6. Batuev A.S. Neuronal mechanisms of goal-directed behaviour in monkeys. International Journal of Neuroscience 1989, 44(1-2):59-66.
7. Beato R., Levy R., Pillon B., Vidal C., du Montcel S.T., Deweer B., et al. Working memory in Parkinson's disease patients: Clinical features and response to levodopa. Arquivos de Neuro-Psiquiatria 2008, 66(2A):147-151.
8. Beck D.C., Carlson G.A., Russell A.T., Brownfield F.E. Use of depression rating instruments in developmentally and educationally delayed adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1987, 26(1):97-100.
9. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979, 205(4409):929-932.
10. Brusa L., Bassi A., Stefani A., Pierantozzi M., Peppe A., Caramia M.D., et al. Pramipexole in comparison to l-dopa: A neuropsychological study. Journal of Neural Transmission 2003, 110(4):373-380.
11. Burn D.J., Rowan E.N., Allan L.M., Molloy S., O'Brien J.T., McKeith I.G. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. Journal of Neurology, Neurosurgery, and Psychiatry 2006, 77(5):585-589.
12. Castner S.A., Goldman-Rakic P.S. Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation. Journal of Neuroscience 2004, 24(6):1446-1450.
13. Chang C., Crottaz-Herbette S., Menon V. Temporal dynamics of basal ganglia response and connectivity during verbal working memory. Neuroimage 2007, 34(3):1253-1269.
14. Charbonneau D., Riopelle R.J., Beninger R.J. Impaired incentive learning in treated Parkinson's disease. Canadian Journal of Neurological Sciences 1996, 23(4):271-278.
15. Cohen J.D., Barch D.M., Carter C., Servan-Schreiber D. Context-processing deficits in schizophrenia: Converging evidence from three theoretically motivated cognitive tasks. Journal of Abnormal Psychology 1999, 108(1):120-133.
16. Cohen J.D., Perlstein W.M., Braver T.S., Nystrom L.E., Noll D.C., Jonides J., et al. Temporal dynamics of brain activation during a working memory task. Nature 1997, 386(6625):604-608.
17. Collins P., Wilkinson L.S., Everitt B.J., Robbins T.W., Roberts A.C. The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function. Behavioral Neuroscience 2000, 114(1):3-17.
18. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cerebral Cortex 2001, 11(12):1136-1143.
19. Cools R., D'Esposito M. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biological Psychiatry 2011, 69(12):e113-125.
20. Cooper J.A., Sagar H.J., Jordan N., Harvey N.S., Sullivan E.V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991, 114(Pt 5):2095-2122.
21. Costa A., Peppe A., Dell'Agnello G., Carlesimo G.A., Murri L., Bonuccelli U., et al. Dopaminergic modulation of visual-spatial working memory in Parkinson's disease. Dementia and Geriatric Cognitive Disorders 2003, 15(2):55-66.
22. Diekamp B., Kalt T., Gunturkun O. Working memory neurons in pigeons. Journal of Neuroscience 2002, 22(4):RC210.
23. Disbrow E.A., Russo K.A., Higginson C.I., Yund E.W., Ventura M.I., Zhang L., et al. Efficacy of tailored computer-based neurorehabilitation for improvement of movement initiation in Parkinson's disease. Brain Research 2012, 1452:151-164.
24. Divac I., Rosvold H.E., Szwarcbart M.K. Behavioral effects of selective ablation of the caudate nucleus. Journal of Comparative and Physiological Psychology 1967, 63(2):184-190.
25. Domellof M.E., Elgh E., Forsgren L. The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease. Movement Disorders 2011, 26(12):2183-2189.
26. Durstewitz D., Seamans J.K., Sejnowski T.J. Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. Journal of Neurophysiology 2000, 83(3):1733-1750.
27. Ecker D., Unrath A., Kassubek J., Sabolek M. Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: A case-control study. BMC Neurology 2009, 9:23.
28. Fernandez-Ruiz J., Doudet D., Aigner T.G. Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeys. Psychopharmacology (Berlin) 1999, 147(1):104-107.
29. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12(3):189-198.
30. Frank M.J., O'Reilly R.C. A mechanistic account of striatal dopamine function in human cognition: Psychopharmacological studies with cabergoline and haloperidol. Behavioral Neuroscience 2006, 120(3):497-517.
31. Gabrieli J.D.E., Singh J., Stebbins G.T., Goetz C.G. Reduced working memory span in Parkinson's disease: Evidence for the role of a frontostriatal system in working and strategic memory. Neuropsychology 1996, 10:322-332.
32. Gazzaley A., Rissman J., Desposito M. Functional connectivity during working memory maintenance. Cognitive, Affective, and Behavioral Neuroscience 2004, 4(4):580-599.
33. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 1995, 14(3):477-485.
34. Goldman-Rakic P.S., Muly E.C., Williams G.V. D(1) receptors in prefrontal cells and circuits. Brain Research Reviews 2000, 31(2-3):295-301.
35. Gotham A.M., Brown R.G., Marsden C.D. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 1988, 111(Pt 2):299-321.
36. Hayhoe M., Aivar P., Shrivastavah A., Mruczek R. Visual short-term memory and motor planning. Progress in Brain Research 2002, 140:349-363.
37. Hikosaka O., Sakamoto M., Usui S. Functional properties of monkey caudate neurons. III. Activities related to expectation of target and reward. Journal of Neurophysiology 1989, 61(4):814-832.
38. Hobson P., Gallacher J., Meara J. Cross-sectional survey of Parkinson's disease and parkinsonism in a rural area of the United Kingdom. Movement Disorders 2005, 20(8):995-998.
39. Hodgson T.L., Dittrich W.H., Henderson L., Kennard C. Eye movements and spatial working memory in Parkinson's disease. Neuropsychologia 1999, 37(8):927-938.
40. Issen L.A., Knill D.C. Decoupling eye and hand movement control: Visual short-term memory influences reach planning more than saccade planning. Journal of Vision 2012, 12(1).
41. Jankovic J., McDermott M., Carter J., Gauthier S., Goetz C., Golbe L., et al. Variable expression of Parkinson's disease: A base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990, 40(10):1529-1534.
42. Judd C.M., McClelland G.H. Data analysis, a model-comparison approach 1989, Harcourt, Orlando, FL.
43. Kassubek J., Juengling F.D., Hellwig B., Spreer J., Lucking C.H. Thalamic gray matter changes in unilateral Parkinsonian resting tremor: A voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neuroscience Letters 2002, 323(1):29-32.
44. Kawagoe R., Takikawa Y., Hikosaka O. Expectation of reward modulates cognitive signals in the basal ganglia. Nature Neuroscience 1998, 1(5):411-416.
45. Kish S.J., Shannak K., Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. The New England Journal of Medicine 1988, 318(14):876-880.
46. Kulisevsky J. Role of dopamine in learning and memory: Implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs and Aging 2000, 16(5):365-379.
47. Kulisevsky J., Avila A., Barbanoj M., Antonijoan R., Berthier M.L., Gironell A. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels. Brain 1996, 119(Pt 6):2121-2132.
48. Kwak Y., Bohnen N.I., Muller M.L., Dayalu P., Burke D.T., Seidler R.D. Task-dependent interactions between Dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease. Behavioral Brain Research 2013.
49. Lange K.W., Robbins T.W., Marsden C.D., James M., Owen A.M., Paul G.M. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berlin) 1992, 107(2-3):394-404.
50. Lee J.M., Koh S.B., Chae S.W., Seo W.K., Kwon do Y., Kim J.H. Postural instability and cognitive dysfunction in early Parkinson's disease. The Canadian Journal of Neurological Sciences 2012, 39(4):473-482.
51. Lees A.J., Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983, 106(Pt 2):257-270.
52. Lewis S.J., Dove A., Robbins T.W., Barker R.A., Owen A.M. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. Journal of Neuroscience 2003, 23(15):6351-6356.
53. Lewis S.J., Dove A., Robbins T.W., Barker R.A., Owen A.M. Striatal contributions to working memory: A functional magnetic resonance imaging study in humans. European Journal of Neuroscience 2004, 19(3):755-760.
54. Lewis S.J., Slabosz A., Robbins T.W., Barker R.A., Owen A.M. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia 2005, 43(6):823-832.
55. Ljungberg T., Apicella P., Schultz W. Responses of monkey dopamine neurons during learning of behavioral reactions. Journal of Neurophysiology 1992, 67(1):145-163.
56. Lyros E., Messinis L., Papathanasopoulos P. Does motor subtype influence neurocognitive performance in Parkinson's disease without dementia?. European Journal of Neurology 2008, 15(3):262-267.
57. Marini P., Ramat S., Ginestroni A., Paganini M. Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: Reversal after L-dopa therapy. Neurol Sci 2003, 24(3):184-185.
58. Matsumoto K., Suzuki W., Tanaka K. Neuronal correlates of goal-based motor selection in the prefrontal cortex. Science 2003, 301(5630):229-232.
59. McIntyre J., Stratta F., Lacquaniti F. Short-term memory for reaching to visual targets: Psychophysical evidence for body-centered reference frames. Journal of Neuroscience 1998, 18(20):8423-8435.
60. Monchi O., Petrides M., Petre V., Worsley K., Dagher A. Wisconsin Card Sorting revisited: Distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. Journal of Neuroscience 2001, 21(19):7733-7741.
61. Moustafa, Herzallah M.M., Gluck M.A. Dissociating the cognitive effects of levodopa vs. dopamine agonists in a neurocomputational model of learning in Parkinson's disease. Neurodegenerative Diseases 2013, 11(2):102-111.
62. Moustafa, Maida A.S. Using TD learning to simulate working memory performance in a model of the prefrontal cortex and basal ganglia. Cognitive Systems Research 2007, 8:262-281.
63. Moustafa, Sherma S.J., Frank M.J. A dopaminergic basis for working memory, learning and attentional shifting in Parkinsonism. Neuropsychologia 2008, 46(13):3144-3156.
64. Mure H., Hirano S., Tang C.C., Isaias I.U., Antonini A., Ma Y., et al. Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects. Neuroimage 2011, 54(2):1244-1253.
65. Obeso J.A., Marin C., Rodriguez-Oroz C., Blesa J., Benitez-Temino B., Mena-Segovia J., et al. The basal ganglia in Parkinson's disease: Current concepts and unexplained observations. Annals of Neurology 2008, 64(Suppl. 2):S30-46.
66. Oh J.Y., Kim Y.S., Choi B.H., Sohn E.H., Lee A.Y. Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD). Archives of Gerontology and Geriatrics 2009, 49(3):351-354.
67. Ohbayashi M., Ohki K., Miyashita Y. Conversion of working memory to motor sequence in the monkey premotor cortex. Science 2003, 301(5630):233-236.
68. Owen A.M. Cognitive dysfunction in Parkinson's disease: The role of frontostriatal circuitry. Neuroscientist 2004, 10(6):525-537.
69. Owen A.M., Doyon J., Dagher A., Sadikot A., Evans A.C. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 1998, 121(Pt 5):949-965.
70. Owen A.M., James M., Leigh P.N., Summers B.A., Marsden C.D., Quinn N.P., et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992, 115(Pt 6):1727-1751.
71. Owen A.M., McMillan K.M., Laird A.R., Bullmore E. N-back working memory paradigm: A meta-analysis of normative functional neuroimaging studies. Human Brain Mapping 2005, 25(1):46-59.
72. Owen A.M., Sahakian B.J., Hodges J.R., Summers B.A., Polkey C.E. Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease. Neuropsychology 1995, 9(1):126-140.
73. Partiot A., Verin M., Pillon B., Teixeira-Ferreira C., Agid Y., Dubois B. Delayed response tasks in basal ganglia lesions in man: Further evidence for a striato-frontal cooperation in behavioural adaptation. Neuropsychologia 1996, 34(7):709-721.
74. Paxton J.L., Barch D.M., Racine C.A., Braver T.S. Cognitive Control, Goal Maintenance, and Prefrontal Function in Healthy Aging. Cerebral Cortex 2007.
75. Perlstein W.M., Carter C.S., Noll D.C., Cohen J.D. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. American Journal of Psychiatry 2001, 158(7):1105-1113.
76. Perlstein W.M., Dixit N.K., Carter C.S., Noll D.C., Cohen J.D. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biological Psychiatry 2003, 53(1):25-38.
77. Piek J.P., Dyck M.J., Nieman A., Anderson M., Hay D., Smith L.M., et al. The relationship between motor coordination, executive functioning and attention in school aged children. Archives of Clinical Neuropsychology 2004, 19(8):1063-1076.
78. Poewe W., Berger W., Benke T., Schelosky L. High-speed memory scanning in Parkinson's disease: Adverse effects of levodopa. Annals of Neurology 1991, 29(6):670-673.
79. Poletti, M., & Bonuccelli, U. (in press). Acute and chronic cognitive effects of levodopa and dopamine agonists in patients with Parkinson's disease:a review. Therapeutic Advances in Psychopharmacology.
80. Poletti M., Emre M., Bonuccelli U. Mild cognitive impairment and cognitive reserve in Parkinson's disease. Parkinsonism Related Disorders 2011, 17(8):579-586.
81. Poletti M., Frosini D., Pagni C., Baldacci F., Giuntini M., Mazzucchi S., et al. The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naive patients with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology 2012.
82. Poletti M., Frosini D., Pagni C., Baldacci F., Nicoletti V., Tognoni G., et al. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 2012, 83(6):601-606.
83. Postle B.R., Jonides J., Smith E.E., Corkin S., Growdon J.H. Spatial, but not object, delayed response is impaired in early Parkinson's disease. Neuropsychology 1997, 11(2):171-179.
84. Probst-Cousin S., Druschky A., Neundorfer B. Disappearance of resting tremor after "stereotaxic" thalamic stroke. Neurology 2003, 61(7):1013-1014.
85. Ranchet M., Paire-Ficout L., Marin-Lamellet C., Laurent B., Broussolle E. Impaired updating ability in drivers with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2011, 82(2):218-223.
86. Sawamoto N., Piccini P., Hotton G., Pavese N., Thielemans K., Brooks D.J. Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain 2008, 131(Pt 5):1294-1302.
87. Schillaci O., Chiaravalloti A., Pierantozzi M., Di Pietro B., Koch G., Bruni C., et al. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: Molecular imaging with 123I-FP-CIT SPECT. International Journal of Molecular Medicine 2011, 28(5):881-886.
88. Shohamy D., Myers C.E., Geghman K.D., Sage J., Gluck M.A. L-dopa impairs learning, but spares generalization, in Parkinson's disease. Neuropsychologia 2006, 44(5):774-784.
89. Taylor A.E., Saint-Cyr J.A., Lang A.E. Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain 1986, 109(Pt 5):845-883.
90. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Movement Disorders 2010, 25(15):2649-2653.
91. Vakil E., Herishanu-Naaman S. Declarative and procedural learning in Parkinson's disease patients having tremor or bradykinesia as the predominant symptom. Cortex 1998, 34(4):611-620.
92. van Wouwe N.C., Ridderinkhof K.R., Band G.P., van den Wildenberg W.P., Wylie S.A. Dose dependent dopaminergic modulation of reward-based learning in Parkinson's disease. Neuropsychologia 2012, 50(5):583-591.
93. Weinberger M., Hutchison W.D., Lozano A.M., Hodaie M., Dostrovsky J.O. Increased gamma oscillatory activity in the subthalamic nucleus during tremor in Parkinson's disease patients. Journal of Neurophysiology 2009, 101(2):789-802.
94. Weintraub D., Koester J., Potenza M.N., Siderowf A.D., Stacy M., Voon V., et al. Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Archives of Neurology 2010, 67(5):589-595.
95. Zaidel A., Arkadir D., Israel Z., Bergman H. Akineto-rigid vs. tremor syndromes in Parkinsonism. Current Opinion in Neurology 2009, 22(4):387-393.